• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pathogens . Neuraminidase in Virus-like Particles Contributes to the Protection against High Dose of Avian Influenza Virus Challenge Infection

tetano

Editor, Senior Moderator
Pathogens


. 2021 Oct 7;10(10):1291.
doi: 10.3390/pathogens10101291.
Neuraminidase in Virus-like Particles Contributes to the Protection against High Dose of Avian Influenza Virus Challenge Infection


Hae-Ji Kang[SUP] 1 [/SUP], Ki-Back Chu[SUP] 1 [/SUP], Keon-Woong Yoon[SUP] 1 [/SUP], Gi-Deok Eom[SUP] 1 [/SUP], Jie Mao[SUP] 1 [/SUP], Min-Ju Kim[SUP] 1 [/SUP], Su-Hwa Lee[SUP] 1 [/SUP], Eun-Kyung Moon[SUP] 2 [/SUP], Fu-Shi Quan[SUP] 2 3 [/SUP]



Affiliations
Free PMC article

Abstract

Neuraminidase is an important target for influenza vaccination. In this study, we generated avian influenza VLPs, expressing hemagglutinin (HA), neuraminidase (NA), HA and NA co-expressed (HANA), to evaluate the protective role of NA against a high (10LD[SUB]50[/SUB]) and low (2LD[SUB]50[/SUB]) dose of avian influenza virus challenge infections. A single immunization with HANA VLPs elicited the highest level of virus-specific IgG, IgG1, and IgG2a responses from the sera post-vaccination and the lungs post-challenge-infection. Potent antibody-secreting cell responses were observed from the spleens and lungs of HANA-VLP-immunized mice post-challenge-infection. HANA VLPs induced the highest CD4[SUP]+[/SUP] T cell, CD8[SUP]+[/SUP] T cell, and germinal center B cells, while strongly limiting inflammatory cytokine production in the lungs compared to other VLP immunization groups. In correlation with these findings, the lowest bodyweight losses and lung virus titers were observed from HANA VLP immunization, and all of the immunized mice survived irrespective of the challenge dose. Contrastingly, VLPs expressing either HA or NA alone failed to elicit complete protection. These results indicated that NA in VLPs played a critical role in inducing protection against a high dose of the challenge infection.

Keywords: avian influenza; neuraminidase; protection; virus-like particle.
 
Back
Top Bottom